Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.
The Harvard Crimson

Former Google CEO Eric Schmidt Warns AI Could Think For Itself In Four Years at Harvard Talk

Former Google CEO Eric E. Schmidt predicted that artificial intelligence will be able to learn from itself within four years ...

AI-Powered Platforms Accelerate Healthcare's Preventative Care Wellness Revolution

Baystreet.ca News Commentary – The artificial intelligence in healthcare market is projected to expand from $17.2 billion in 2025 to $77.2 billion by 2035 as digital transformation and ...

Miss These Genesis Mission Stocks, and You’ll Regret It for a Decade

These are some of the fastest, biggest gains I’ve seen in my career.  But they were just the appetizer.  The main course? The Genesis Mission – the single most important investment theme of ...
Scientific Research Publishing

Modelling Infectious Diseases: SEIR-SEI Compartmental Model on Malaria ()

Infectious diseases such as bacterial, viral, fungal and parasitic diseases continue to have a significant impact on global health. Hence, knowledge on how infection spread, population vulnerable to ...